Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antipseudomonal β-Lactams Resistance in Iran.
Rabiei MM, Asadi K, Shokouhi S, Nasiri MJ, Alavi Darazam I. Rabiei MM, et al. Int J Microbiol. 2020 Dec 16;2020:8818315. doi: 10.1155/2020/8818315. eCollection 2020. Int J Microbiol. 2020. PMID: 33488724 Free PMC article. Review.
Brucellosis in transplant recipients: A systematic review.
Rabiei MM, Imanzade F, Hatami F, Hesami H, Irvani SSN, Alavi Darazam I. Rabiei MM, et al. Transpl Infect Dis. 2021 Aug;23(4):e13604. doi: 10.1111/tid.13604. Epub 2021 Mar 27. Transpl Infect Dis. 2021. PMID: 33743545 Review.
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi MA, Rabiei MM, Hatami F, Shabani M, Moradi O, Gharehbagh FJ, Irvani SSN, Amirdosara M, Hajiesmaeili M, Rezaei O, Khoshkar A, Lotfollahi L, Gachkar L, Dehbsneh HS, Khalili N, Soleymaninia A, Kusha AH, Shoushtari MT, Torabinavid P. Alavi Darazam I, et al. Among authors: rabiei mm. Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10. Int Immunopharmacol. 2021. PMID: 34273635 Free PMC article. Review.
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.
Alavi Darazam I, Kazempour M, Pourhoseingholi MA, Hatami F, Rabiei MM, Javandoust Gharehbagh F, Amirdosara M, Hajiesmaeili M, Shabani M, Shokouhi S, Lotfollahi L, Mardani M, Haghighi-Morad M, Nassiri AA, Rangraz D, Falahaty H, Syami H, Irannejad Y, Fallah M, Zangi M, Shafigh N. Alavi Darazam I, et al. Among authors: rabiei mm. Blood Purif. 2023;52(1):8-16. doi: 10.1159/000524606. Epub 2022 May 17. Blood Purif. 2023. PMID: 35580567 Free PMC article.
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Alavi Darazam I, Hatami F, Rabiei MM, Pourhoseingholi MA, Moradi O, Shokouhi S, Hajesmaeili MR, Shabani M, Irvani SSN. Alavi Darazam I, et al. Among authors: rabiei mm. Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2. Trials. 2020. PMID: 33106183 Free PMC article. Clinical Trial.
21 results